Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 98,679	$ 20,323
Marketable securities	39,463
Prepaid expenses and other current assets	6,561	2,326
Total current assets	144,703	22,649
Property and equipment, net	2,073	681
Operating right-of-use asset, net	1,564	284
Restricted cash	100	100
Deferred offering costs		332
Other long-term assets	100
Total assets	148,540	24,046
Current liabilities:
Accounts payable	3,311	2,400
Accrued expenses and other current liabilities	8,025	4,931
Deferred revenue, current	10,493
Total current liabilities	21,829	7,331
Deferred revenue, non-current	5,489
Other long-term liabilities	1,340	62
Total liabilities	28,658	7,393
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2023 and 2022
Common stock, $0.0001 par value; 200,000,000 shares authorized; 43,251,778 shares issued and outstanding at December 31, 2023 and 12,128,843 shares issued and outstanding at December 31, 2022	4	1
Additional paid-in capital	342,663	132,653
Accumulated other comprehensive income	22
Accumulated deficit	(222,807)	(116,001)
Total stockholders' equity	119,882	16,653
Total liabilities and stockholders' equity	$ 148,540	$ 24,046